Genetic profile of borderline ovarian tumors in the Lebanese population by whole-exome sequencing

Int J Gynaecol Obstet. 2023 Sep;162(3):1027-1032. doi: 10.1002/ijgo.14805. Epub 2023 Apr 25.

Abstract

Objective: To assess the molecular profile of borderline ovarian tumors (BOT) in the Lebanese population by whole-exome sequencing and to correlate the results with the patients' clinical profiles.

Methods: We included in this retrospective study 33 tumors belonging to 32 Lebanese women presenting with BOT, diagnosed at Hôtel Dieu de France. A total of 234 genes involved in different germinal and somatic types of cancer were analyzed using next-generation sequencing.

Results: Molecular analysis of these tumors allowed us to detect mutations in genes involved in the mitogen-activated protein kinase cascade in 57.58% of BOT and to identify variants affecting the DNA repair mechanism in 63.89% of samples. Furthermore, our initial analysis revealed an association between defects in DNA double-strand break repair and the occurrence of mucinous BOT, in 75% of the cases.

Conclusion: This study reports the molecular profiles of BOT in the Lebanese population and compares them to the literature. This is the first study associating the DNA repair pathway to BOT.

Keywords: Lebanon; borderline ovarian tumors; cancer; exome; genetics; mucinous; next-generation sequencing; serous.

MeSH terms

  • Exome Sequencing
  • Female
  • France
  • Genetic Profile*
  • Humans
  • Ovarian Neoplasms* / genetics
  • Retrospective Studies

Grants and funding